UT Health San Antonio | The University of Texas Health Science Center at San Antonio
Category ID
106

Required COVID-19 precautions as community risk level worsens

<p>Based on data reported to the Centers for Disease Control and Prevention (CDC) as of July 28 2022, Bexar County’s COVID-19 community risk level remains high and worsening. The BA.5 variant is highly contagious and can infect people who have had prior infections and those who are vaccinated against COVID-19. Still, vaccinations have proven to reduce the severity of the illness, reducing the number of hospitalizations.</p>

Share This Story

Announcing the inaugural dean for The University of Texas School of Public Health San Antonio

<p>We are delighted to announce the appointment of Vasan S. Ramachandran, MD, as the founding Dean of The University of Texas School of Public Health San Antonio, a strategic collaboration between UT Health San Antonio and The University of Texas at San Antonio (UTSA). Dr. Ramachandran serves currently as the Jay and Louise Coffman Professor [&hellip;]</p>

Share This Story

Register your mobile number to receive HSC Alert text messages

<p>Receive emergency alerts as text messages on your mobile phone, or sent to your personal email address, in HSC Alert. </p>

Share This Story

Nursing professor prioritizes community health

<p>Adelita Cantu, PhD, RN, FAAN, is no stranger to media coverage in her hometown of San Antonio. As a UT Health San Antonio School of Nursing associate professor in the Department of Family and Community Health Systems, she made headlines for being among the first recipients of the COVID-19 vaccine when it became available in [&hellip;]</p>

Share This Story

Nathan Wiederhold receives Billy H. Cooper Award for contributions to diagnostic clinical mycology

<p>Nathan Wiederhold, PharmD, professor of pathology and laboratory medicine and director of the Fungus Testing Laboratory at UT Health San Antonio, received the Medical Mycological Society of the Americas Billy H. Cooper Award for continued outstanding contributions to the practice of diagnostic clinical mycology. Wiederhold is highly involved in preclinical studies of antifungal agents and [&hellip;]</p>

Share This Story

Planned power outage set for August 12

<p>A power outage for the Dental Building, Basic Science Building, adjacent lecture halls and Garage B has been scheduled for August 12 from 8:00 p.m. to 2:00 a.m.</p>

Share This Story

Internal Medicine Residency Program gains health equity curriculum grant

<p>With financial support from leading internal medicine organizations, UT Health San Antonio will launch “Promotores and Residents in Internal Medicine for Equity (PRIME): A Collaborative Health Equity Curriculum.” According to the principal investigators, Jason Morrow, MD, and Elena Jiménez Gutiérrez, MD, this transformational program will help diverse community members and medical professionals better understand each [&hellip;]</p>

Share This Story

Nathan Wiederhold receives Billy H. Cooper Award for contributions to diagnostic clinical mycology

<p>Nathan Wiederhold, PharmD, professor of pathology and laboratory medicine and director of the Fungus Testing Laboratory at UT Health San Antonio, received the Medical Mycological Society of the Americas Billy H. Cooper Award for continued outstanding contributions to the practice of diagnostic clinical mycology. Wiederhold is highly involved in preclinical studies of antifungal agents and [&hellip;]</p>

Share This Story

Spreading the word about the value of medical research

<p>Did you know that older Hispanic adults are estimated to be at 1.5 times greater risk of Alzheimer’s and other dementias than non-Hispanic whites? That fact alone makes research efforts in the area of brain health essential for improving the lives of South Texas residents. More genetic variations for Alzheimer’s disease are known today than [&hellip;]</p>

Share This Story

New therapy significantly reduces headache disability, post-traumatic stress after brain injury, study finds

<p>Note: This article was produced and contributed by Joel Williams and Julie Collins. The first therapy to be developed specifically for post-traumatic headache significantly reduced related disability in veterans following a traumatic brain injury (TBI). It also reduced co-occurring symptoms of post-traumatic stress disorder (PTSD) comparably to a gold-standard PTSD treatment. Moreover, the innovative treatment, [&hellip;]</p>

Share This Story

Subscribe to My UT Health